NCT04499066 is a clinical trial in Depression, sponsored by Guangzhou Women and Children's Medical Center.

Who is sponsoring NCT04499066?

NCT04499066 is sponsored by Guangzhou Women and Children's Medical Center.

What condition does NCT04499066 study?

NCT04499066 studies Depression, Anxiety.

Is NCT04499066 still recruiting?

NCT04499066 is currently recruiting now. Last updated 13 September 2023.

Last reviewed 2023-09-13 · How we verify

NCT04499066

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Peripartum Mental Health Cohort Study in Guangzhou

Recruiting now Last updated 13 September 2023

What this trial tests

trial in Depression in 3,000 participants. Currently enrolling.

Timeline

1 February 2012

Primary endpoint
31 December 2025

31 December 2038

Quick facts

Lead sponsor	Guangzhou Women and Children's Medical Center
Status	Recruiting now
Study type	OBSERVATIONAL
Enrollment	3,000
Start date	1 February 2012
Primary completion	31 December 2025
Estimated completion	31 December 2038
Sites	1 location across China

Conditions studied

Depression — all drugs for Depression →
Anxiety — all drugs for Anxiety →

Sponsor

Guangzhou Women and Children's Medical Center

Who can join

Eligibility, female only, with Depression or Anxiety. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to determine the incidence,development trajectory and risk factors of the main peripartum mental health problems as well as explore its adverse outcomes.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Depression

Currently open trials in the same condition.

NCT07336238 — Group Retreat Psilocybin Therapy for the Treatment of Anxiety and Depression in Patients With Metastatic Solid Tumors or · Phase 2 · recruiting
NCT06906939 — A Randomized Pilot rTMS Trial for Knee Arthritis Pain and Depression · EARLY_PHASE1 · recruiting
NCT07517549 — Sexual Health Education During Pregnancy · NA · recruiting
NCT06408246 — ACE-D Aim 3 Clinical Cognitive Trial to Enhance Translation in Depression · Phase 2 · recruiting
NCT07449676 — Effects of an Innovative TCM-based Tui Jing Therapy on Psychological and Neurophysiological Functions in Depression · NA · recruiting

Other Guangzhou Women and Children's Medical Center trials

Trials by the same sponsor.

NCT07190001 — YOLT-204 in Patients With Hemoglobinopathies · EARLY_PHASE1 · not yet recruiting
NCT06904729 — Chimeric Antigen Receptors T Cells for Refractory/Recurrent Lupus Nephritis in Children · Phase 3 · recruiting
NCT06948994 — A Clinical Trial on Autologous NK Cells Combined With GD2 Monoclonal Antibody in the Treatment of Children With Newly Di · Phase 1, PHASE2 · not yet recruiting
NCT06856759 — Single-Dose AAV-MECP2 Safety/Tolerability and Efficacy in Rett Syndrome · EARLY_PHASE1 · recruiting
NCT06731205 — Long-term Renal Prognosis of Neonatal Acute Kidney Injury · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04499066 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Guangzhou Women and Children's Medical Center
Last refreshed: 13 September 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04499066.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing